, Tracking Stock Market Picks
Enter Symbol:
Bruker Biosciences Corporation (BRKR) [hlAlert]

down 8.50 %

Bruker Biosciences Corporation (BRKR) rated Buy with price target $27 by Maxim Group

Posted on: Friday,  Sep 27, 2013  8:25 AM ET by Maxim Group

Maxim Group rated Buy Bruker Biosciences Corporation (NASDAQ: BRKR) on 09/27/2013, when the stock price was $20.47. Since
then, Bruker Biosciences Corporation has lost 8.50% as of 01/28/2016's recent price of $18.73.
If you would have followed this Maxim Group's recommendation on BRKR, you would have lost 8.5% of your investment in 853 days.

Bruker Corporation designs, manufactures, markets and services life science and materials research systems and associated products to address the needs of its customers in life science research and pharmaceutical, biotechnology and molecular diagnostics research, as well as in materials and chemical analysis in various industries and government applications. Its core technology platforms include X-ray technologies, magnetic resonance technologies, mass spectrometry technologies, optical emission spectroscopy and infrared and Raman molecular spectroscopy technologies. It also manufactures and distributes a range of field analytical systems for chemical, biological, radiological and nuclear (CBRN), detection, as well as superconducting wire products and devices. It operates in four divisions: Bruker AXS, Bruker Daltonics, Bruker Optics and Bruker BioSpin.

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/27/2013 8:25 AM Buy
20.47 27.00
as of 12/13/2013
1 Week down  -2.00 %
1 Month down  -2.05 %
3 Months down  -9.08 %
1 YTD down  -9.08 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy